You searched for "gender"
Medical Journals and The Journal of Laryngology and Otology
Medical journals have a fascinating history. One early journal, The Lancet, was founded in 1823 and its first Editor, London surgeon Thomas Wakley (1795-1862), had a turbulent life. He lived in an era where quackery was rife and where the...Development of a new negative-pressure ventilatory support device: Exovent
The pandemic has driven innovation in ways that we have not seen for many decades. Intensive care medicine and ENT have been at the forefront of these advances, and our good friends David Howard (never one to put his feet...Person-centred hearing care in China
A number of significant steps forward in person-centred care have taken place in China. The Person-centred Care Hearing Research Center (PCCHRC) was established in Xuzhou Medical University in China on 18 April 2025. At the same time, the PCC Alliance...ENT Masterclass® Vietnam
Held for the first time in Southeast Asia, the ‘Facing the World’ ENT Masterclass®, took place successfully in Hanoi – Vietnam’s historic capital with a thousand years of cultural heritage. Hosted and sponsored by Facing the World and Hong Ngoc - Phuc Truong Minh General Hospital in conjunction with ENT Masterclass®, this event marked the organisations’ most significant undertaking to date.
Predictors of complications in patients undergoing oral cavity cancer surgery
Surgical management of oral cavity cancers is complex, frequently involving extensive resections and complicated reconstructions. Quantification of risk in an individual patient may allow surgeons to more effectively identify patients at higher risk of complications and develop strategies for prevention,...
Surgical management of refractory osteoradionecrosis
This is a French single-centre, 10-year experience of 55 surgical resection and reconstruction procedures. They claim an overall effectiveness rate of 92.3%. A total of 36 segmental and 19 marginal mandibulectomies were performed. A variety of free flaps were used,...
A new era in the treatment of recalcitrant nasal polyps?
Chronic rhinosinusitis with nasal polyps (CRSwNP) can be difficult to treat effectively in patients with aggressive or recalcitrant disease. Omalizumab (Xolair) is a monoclonal anti-IgE antibody with proven benefits for patients with moderate/severe asthma and CRSwNP, but this study looks...
